PMID- 19012209
OWN - NLM
STAT- MEDLINE
DCOM- 20090226
LR  - 20081117
IS  - 0171-6425 (Print)
IS  - 0171-6425 (Linking)
VI  - 56
IP  - 8
DP  - 2008 Dec
TI  - Tricuspid valve replacement: an analysis of risk factors and outcomes.
PG  - 456-60
LID - 10.1055/s-2008-1038730 [doi]
AB  - BACKGROUND: Tricuspid valve replacement (TVR) is rarely performed and is 
      associated with a high morbidity and mortality. We report our experience with TVR 
      and related adverse events. METHODS: Between January 1996 and December 2007, 35 
      patients underwent TVR with mechanical (n = 33) or bioprosthetic (n = 2) valves. 
      Twenty-nine patients underwent concomitant cardiac procedures. RESULTS: All 
      patients completed follow-up (mean 47 months). Thirty-day mortality was 20 % (n = 
      7). Risk factors included perioperative low arterial blood pressure ( P = 0.000), 
      New York Heart Association (NYHA) functional class III or IV ( P = 0.001), severe 
      pulmonary hypertension (pulmonary arterial pressure greater than 60 mmHg) ( P = 
      0.000), hepatic dysfunction ( P = 0.000), ascites ( P = 0.003), and reoperation ( 
      P = 0.015). Late mortality occurred in five patients. Valve-related complications 
      included bleeding (n = 1) and stroke (n = 1). Kaplan-Meier estimates of 1-, 5- 
      and 10-year survival (including early mortality) and event-free survival were 
      77.1 %, 60 %, and 54.3 % and 91.1 %, 80.6 %, and 55.9 %, respectively. Severe 
      pulmonary hypertension was the only predictor of late mortality ( P = 0.001). 
      Among survivors, the mean NYHA class improved from 2.8 to 1.1 ( P = 0.000). 
      CONCLUSIONS: Although early outcome after TVR is suboptimal, long-term survival 
      and functional improvement is satisfactory.
FAU - Civelek, A
AU  - Civelek A
AD  - Department o Cardiovascular Surgery, Marmara University School of Medicine, 
      Istanbul, Turkey. alicivelek@tnn.net
FAU - Ak, K
AU  - Ak K
FAU - Akgun, S
AU  - Akgun S
FAU - Isbir, S C
AU  - Isbir SC
FAU - Arsan, S
AU  - Arsan S
LA  - eng
PT  - Journal Article
DEP - 20081114
PL  - Germany
TA  - Thorac Cardiovasc Surg
JT  - The Thoracic and cardiovascular surgeon
JID - 7903387
SB  - IM
MH  - Ascites/complications
MH  - Bioprosthesis
MH  - Blood Pressure
MH  - Female
MH  - Follow-Up Studies
MH  - *Heart Valve Prosthesis
MH  - Heart Valve Prosthesis Implantation/mortality
MH  - Humans
MH  - Hypertension, Pulmonary/complications
MH  - Liver Diseases/complications
MH  - Male
MH  - Reoperation
MH  - Risk Factors
MH  - *Tricuspid Valve
EDAT- 2008/11/18 09:00
MHDA- 2009/02/27 09:00
CRDT- 2008/11/18 09:00
PHST- 2008/11/18 09:00 [pubmed]
PHST- 2009/02/27 09:00 [medline]
PHST- 2008/11/18 09:00 [entrez]
AID - 10.1055/s-2008-1038730 [doi]
PST - ppublish
SO  - Thorac Cardiovasc Surg. 2008 Dec;56(8):456-60. doi: 10.1055/s-2008-1038730. Epub 
      2008 Nov 14.